Psychedelic PR & Media Relations

“Brad  has played a pivotal role in shaping a new cultural narrative where  psychedelics are becoming mainstream, and the balance has shifted toward  hope for their healing and spiritual potentials.”

—RICK DOBLIN, PhD, Founder and President, Multidisciplinary Association for Psychedelic Studies (MAPS)

“Brad  has perfect instincts for the psychedelic field, with an incredibly  rich understanding of where it's been and where it's headed. For over  four years, he's helped Fireside Project navigate complex strategy  questions and secure coverage in Rolling Stone, Esquire, Forbes,  TechCrunch, and more. While he's superb at communications and press  relations, Brad's brilliance goes much deeper—there's no one I trust  more in the psychedelic field."


—JOSHUA WHITE, Founder and Executive Director, Fireside Project

"Working  with Brad has been a pleasure. Significant industry knowledge guides  his work after many years working in the psychedelic field, and it shows  in strategy discussions about what we explore together. I'd highly  recommend Brad and his team if you are seeking public relations and  communications services in the psychedelic space.”


—MIKE LJUBSA, Business Director, MycoMeditations

 We identify and pitch the journalists, editors, and producers most relevant to your work — from regional media and trade publications to top-tier outlets covering mental health, public policy, and psychedelic science. Our outreach is targeted, personalized, and grounded in real relationships. 

 We help psychedelic organizations develop a clear, compelling public story — one that resonates with patients, healthcare professionals, investors, and policymakers alike. From messaging frameworks to brand positioning, we build the foundation that all communications build from 

 We support federal and state advocacy campaigns, drug policy reform efforts, and public education initiatives. Whether you are working with legislators, regulators like Health Canada, or coalition partners, we develop communications that advance the policy conversation. 

 We work with clinical research organizations, CNS-focused companies, and academic institutions to communicate trial results, research milestones, and scientific findings in ways that are accurate, accessible, and strategically timed for maximum media impact. 

 When a story goes wrong, preparation is everything. We help psychedelic organizations identify reputational vulnerabilities, develop response protocols, and navigate difficult media moments with clarity and confidence — protecting your brand without abandoning your mission. 

 As the psychedelic industry matures and attracts venture capital and growth-stage investment, your communications need to speak credibly to financial and professional services audiences. We help organizations tell the right story to the right rooms.